ExecPay

ExecPay

Mutya Harsch

Overview 2022 2021 2020

Overview

Mutya Harsch received an average of $958K in total compensation, including $382K in salary, at VYNE Therapeutics from 2020 to 2022.

2022VYNE TherapeuticsChief Legal Officer, General Counsel and Secretary

2021VYNE TherapeuticsChief Legal Officer, General Counsel and Secretary

2020VYNE TherapeuticsChief Legal Officer, General Counsel and Secretary

Source: SEC filings on November 13, 2023, June 17, 2022, and June 7, 2021.

Harsch's 2022 pay

Related executives

We found seven more executives who work or worked at VYNE Therapeutics.

David Domzalski

VYNE Therapeutics

Chief Executive Officer

Iain Stuart

VYNE Therapeutics

Chief Scientific Officer

Steven Basta

VYNE Therapeutics

Chief Executive Officer

Andrew Saik

VYNE Therapeutics

Chief Financial Officer

Kristine Ball

VYNE Therapeutics

Chief Financial Officer

Paul Kwon

VYNE Therapeutics

Chief Scientific Officer

Mary Spellman

VYNE Therapeutics

Chief Medical Officer

News

VYNE Therapeutics CEO David Domzalski's 2022 pay falls 73% to $1.3M

November 13, 2023

VYNE Therapeutics CEO David Domzalski's 2021 pay jumps 69% to $4.9M

June 17, 2022

VYNE Therapeutics CEO David Domzalski receives $2.9M in 2020

June 7, 2021

You may also like

VYNE Therapeutics

Latest

Flex Pharma CEO David and's 2023 pay falls 42% to $545K

November 1, 2024

Quantum Computing CFO Chris Boehmler's 2023 pay jumps 44% to $611K

November 1, 2024

Gulf Resources CFO Min Li's 2023 pay slips 7% to $78K

November 1, 2024

Akers Biosciences Chief Medical Officer Christopher Chapman's 2023 pay jumps 1,002% to $2.9M

November 1, 2024

2023 ranking

Scott Myers$36M

Signal Genetics

Scilex Holding Co

Mattel

Timothy Hwang$19M

FiscalNote Holdings

Jeff Arnold$18M

Sharecare

More top executives